YSB

YSB Net Debt per Share

The Net Debt per Share of YSB (9885.HK) as of Nov 20, 2026 is -0.94 CNY. In the previous year, Net Debt per Share was -2.27 CNY — a change of -58.72% (higher).

Net Debt per Share

-0.94CNY

YoY

-58.72%

Last updated:

Net Debt per Share of YSB is 2025 -0.94 CNY. Net Debt per Share of YSB was 2024 -2.27 CNY. It decreases by -58.72% higher compared to the previous year.

The YSB Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2020
-0.46 CNY
Jan 1, 2021
-1.46 CNY
Jan 1, 2022
-2.18 CNY
Jan 1, 2023
-2.10 CNY
Jan 1, 2024
-2.27 CNY
Jan 1, 2025
-0.94 CNY
The YSB Net Debt per Share history
YEARNet Debt per ShareYoY
-0.94CNY-58.72%
-2.27CNY+8.26%
-2.10CNY-3.97%
-2.18CNY+49.66%
-1.46CNY+216.95%
-0.46CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

Net Debt per Share of YSB is -0.94 CNY in 2025.

Net Debt per Share of YSB changed from -2.27 CNY to -0.94 CNY, representing a -58.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share YSB since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — YSB

All Key Metrics — YSB